What are the best treatments for Twin-Twin Transfusion Syndrome?

Twin-Twin Transfusion Syndrome (TTTS) is a serious condition affecting identical twins sharing a placenta, characterized by imbalanced blood flow between fetuses. The gold-standard treatment for moderate to severe cases is fetoscopic laser photocoagulation (FLP), which seals the abnormal vascular connections to equalize blood volume and improve outcomes for both twins.

What is the primary treatment for Twin-Twin Transfusion Syndrome?

For cases classified as Quintero stage II or higher, fetoscopic laser photocoagulation is the preferred intervention. During this procedure, a surgeon uses a laser to disrupt the communicating blood vessels on the surface of the placenta. In earlier stages or milder cases, physicians may opt for amnioreduction (the removal of excess amniotic fluid) or selective fetocide, though the latter is reserved for complex, high-risk scenarios where the survival of one twin is otherwise impossible.

Which specialists are involved in the care team?

Managing Twin-Twin Transfusion Syndrome requires a highly specialized multidisciplinary team. Because this condition involves complex fetal hemodynamics, care is typically coordinated by:

• Maternal-Fetal Medicine (MFM) specialists: Experts in high-risk pregnancies and fetal surgery.


• Pediatric Cardiologists: To monitor heart function in the recipient twin, who is at risk of cardiac failure.


• Neonatologists: To manage care for the twins immediately following preterm birth.


• Genetic Counselors: To provide context on the nature of monochorionic pregnancies.

How does treatment effectiveness vary?

Treatment success for Twin-Twin Transfusion Syndrome depends heavily on the stage of the disease at diagnosis and the gestational age. While laser surgery boasts a survival rate of at least one twin in approximately 80–90% of cases, neurodevelopmental outcomes can vary. Patients should be aware that outcomes for Twin-Twin Transfusion Syndrome are highly individual, and long-term follow-up is necessary to monitor for potential neurological or cardiac complications in the survivors.

Are there emerging treatments?

Current research into Twin-Twin Transfusion Syndrome is focused on improving surgical techniques, such as the "Solomon technique," which involves creating a line of laser coagulation across the placenta to prevent recurrent vascular shunts. Ongoing clinical trials are also investigating the role of fetal echocardiography to better predict cardiac recovery post-surgery.

Next steps

• Consult a maternal-fetal medicine specialist at a center of excellence for fetal surgery.


• Join the DiseaseMaps.org community to connect with others who have navigated a Twin-Twin Transfusion Syndrome diagnosis.


• Ensure your care team includes a pediatric cardiologist to monitor for fetal cardiac strain.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with your healthcare provider for personalized diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Rare Disease Database


• Fetal Health Foundation - TTTS Resources


• The North American Fetal Therapy Network (NAFTNet)